Noetik
Noetik is a biotechnology company specializing in cancer research and therapy development. They utilize advanced machine learning techniques to analyze tumor data and improve clinical trial outcomes. Their primary customers include pharmaceutical companies and research institutions seeking to enhance drug development processes. Noetik's innovative approach aims to identify effective cancer treatments and optimize patient selection for clinical trials.
Headcount
Website visitors
Workforce
Headcount by location
- United States100%
Split by department
- Engineering & R&D53%
- Healthcare13%
- Founder, Owner & Executive10%
- Operations7.5%
- Other18%
Seniority distribution
- Less than 5 years85%
- 30 years and more7.3%
- 5 to 10 years4.9%
- 10 to 20 years2.4%
Funding
Raised to date
- 7 May 2026Company AcquisitionUndisclosedGsk
- 29 Aug 2024Series A$40.0M11.2 Capital, ApSTAT Technologies, Breakout Ventures, Catalio Capital Management, Dcvc, EPIC Ventures, Intermountain Health, Khosla Ventures, Polaris Partners, Wittington Ventures, Zetta Venture Partners
3 earlier rounds, with their terms and sources.
Investors
Khosla VenturesKhosla Ventures is a venture capital firm based in Menlo Park, California, specializing in early-stage investments across various sectors including technology and healthcare. The firm provides capital and strategic support to startups, helping them751United States
Polaris PartnersPolaris Partners is a venture capital firm specializing in investment management and support for healthcare and biotechnology companies. They collaborate with entrepreneurs to foster innovation and help bring transformative solutions to market.283United States
DcvcDCVC is a venture capital firm specializing in deep tech investments. It supports entrepreneurs addressing significant global challenges through funding and advisory services. With a focus on AI and computational approaches, DCVC aims to create257United States
aVenture (Techstars '23)aVenture is a venture capital research platform that provides detailed analysis and data on startups and venture capital investments. It serves investors and organizations seeking insights to inform their investment decisions. The platform operates146United States
Revenue
EBITDA
Revenue source: Modeled estimate
Recent news
- Noetik revenue.has revenue
- Bruker Corporation. (2/24/26). "Press release: Bruker expands collaboration with Noetik to advance tissue foundational models for translational and therapeutic applications". Orlando, FL.partners with
- Bruker expands collaboration with Noetikpartners with
- Agenus and Noetik Collaboration Will Predict Cancer Biomarkers Using the Virtual Cellis developing
People
How the team has changed month by month — joiners, leavers and where the hiring is going
Connections
Who at your firm already knows someone here, and how warm the path is
The full Noetik profile lives in Inven.
Your competitors are already on Inven
See how Inven turns hours of manual research into a single, structured workflow.